China Cancer Biomarkers Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer.

    This report elaborates on the current development of the Cancer Biomarkers industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • FHoffmann-La Roche Ltd

    • QIAGEN

    • Abbott Laboratories

    • Bio-Rad Laboratories, Inc

    • Hologic

    • Quest Diagnostics

    • Agilent Technologies

    • Biomérieux SA

    • Exact Sciences Corporation

    • Sysmex Corporation

    • Bristol-Myers Squibb Company

    • Becton, Dickinson and Company

    • Roche Diagnostics

    By Type:

    • Genetic Biomarkers

    • Protein Biomarkers

    • Glyco-biomarkers

    By Application:

    • Risk Assessment

    • Drug Discovery and Development

    • Others

    • Diagnostics

    • Prognostics

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Cancer Biomarkers Market Overview 2018-2029

    • 1.1 China Cancer Biomarkers Industry Development Overview

    • 1.2 China Cancer Biomarkers Industry Development History

    • 1.3 China Cancer Biomarkers Industry Market Size (2018-2029)

    • 1.4 China Cancer Biomarkers Market Analysis by Type from Production Side

      • 1.4.1 China Cancer Biomarkers Production Volume, Production Value and Growth Rate of Genetic Biomarkers (2018-2029)

      • 1.4.2 China Cancer Biomarkers Production Volume, Production Value and Growth Rate of Protein Biomarkers (2018-2029)

      • 1.4.3 China Cancer Biomarkers Production Volume, Production Value and Growth Rate of Glyco-biomarkers (2018-2029)

    • 1.5 China Cancer Biomarkers Market Analysis by Application from Consumption End

      • 1.5.1 China Cancer Biomarkers Sales Volume, Sales Value and Growth Rate of Risk Assessment (2018-2029)

      • 1.5.2 China Cancer Biomarkers Sales Volume, Sales Value and Growth Rate of Drug Discovery and Development (2018-2029)

      • 1.5.3 China Cancer Biomarkers Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.4 China Cancer Biomarkers Sales Volume, Sales Value and Growth Rate of Diagnostics (2018-2029)

      • 1.5.5 China Cancer Biomarkers Sales Volume, Sales Value and Growth Rate of Prognostics (2018-2029)

    • 1.6 China Cancer Biomarkers Market Analysis by Region

      • 1.6.1 North China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

    Chapter 2 China Cancer Biomarkers Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Cancer Biomarkers Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Cancer Biomarkers Market Status and Competition Analysis in 2023

      • 2.2.3 China Cancer Biomarkers Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Cancer Biomarkers Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Cancer Biomarkers Industry Development

    Chapter 3 Cancer BiomarkersIndustry Chain Analysis

    • 3.1 Cancer Biomarkers Industry Chain

    • 3.2 Cancer Biomarkers Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Cancer Biomarkers Market

    • 3.3 Cancer Biomarkers Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Cancer Biomarkers Market

    Chapter 4 China Cancer Biomarkers Market, by Type

    • 4.1 China Cancer Biomarkers Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Cancer Biomarkers Total Production Volume and Growth Rate from Production Side

    • 4.5 China Cancer Biomarkers Production Volume and Growth Rate, by Type

      • 4.5.1 China Cancer Biomarkers Production Volume and Growth Rate of Genetic Biomarkers

      • 4.5.2 China Cancer Biomarkers Production Volume and Growth Rate of Protein Biomarkers

      • 4.5.3 China Cancer Biomarkers Production Volume and Growth Rate of Glyco-biomarkers

    Chapter 5 China Cancer Biomarkers Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Cancer Biomarkers Total Market Size and Growth Rate from Consumption End

    • 5.5 China Cancer Biomarkers Market Size and Growth Rate, by Application

      • 5.5.1 China Cancer Biomarkers Market Size and Growth Rate of Risk Assessment

      • 5.5.2 China Cancer Biomarkers Market Size and Growth Rate of Drug Discovery and Development

      • 5.5.3 China Cancer Biomarkers Market Size and Growth Rate of Others

      • 5.5.4 China Cancer Biomarkers Market Size and Growth Rate of Diagnostics

      • 5.5.5 China Cancer Biomarkers Market Size and Growth Rate of Prognostics

    Chapter 6 China Cancer Biomarkers Market, by Region

    • 6.1 China Cancer Biomarkers Production Volume and Production Value, by Region

    • 6.2 China Cancer Biomarkers Sales Volume and Sales Value, by Region

    Chapter 7 North China Cancer Biomarkers Market Analysis

    • 7.1 North China Cancer Biomarkers Market, by Type

    • 7.2 North China Cancer Biomarkers Market, by Application

    Chapter 8 Central China Cancer Biomarkers Market Analysis

    • 8.1 Central China Cancer Biomarkers Market, by Type

    • 8.2 Central China Cancer Biomarkers Market, by Application

    Chapter 9 South China Cancer Biomarkers Market Analysis

    • 9.1 South China Cancer Biomarkers Market, by Type

    • 9.2 South China Cancer Biomarkers Market, by Application

    Chapter 10 East China Cancer Biomarkers Market Analysis

    • 10.1 East China Cancer Biomarkers Market, by Type

    • 10.2 East China Cancer Biomarkers Market, by Application

    Chapter 11 Northeast China Cancer Biomarkers Market Analysis

    • 11.1 Northeast China Cancer Biomarkers Market, by Type

    • 11.2 Northeast China Cancer Biomarkers Market, by Application

    Chapter 12 Southwest China Cancer Biomarkers Market Analysis

    • 12.1 Southwest China Cancer Biomarkers Market, by Type

    • 12.2 Southwest China Cancer Biomarkers Market, by Application

    Chapter 13 Northwest China Cancer Biomarkers Market Analysis

    • 13.1 Northwest China Cancer Biomarkers Market, by Type

    • 13.2 Northwest China Cancer Biomarkers Market, by Application

    Chapter 14 Company Profiles

      • 14.1 FHoffmann-La Roche Ltd

        • 14.1.1 FHoffmann-La Roche Ltd Company Profile

        • 14.1.2 FHoffmann-La Roche Ltd Cancer Biomarkers Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 QIAGEN

        • 14.2.1 QIAGEN Company Profile

        • 14.2.2 QIAGEN Cancer Biomarkers Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Abbott Laboratories

        • 14.3.1 Abbott Laboratories Company Profile

        • 14.3.2 Abbott Laboratories Cancer Biomarkers Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Bio-Rad Laboratories, Inc

        • 14.4.1 Bio-Rad Laboratories, Inc Company Profile

        • 14.4.2 Bio-Rad Laboratories, Inc Cancer Biomarkers Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Hologic

        • 14.5.1 Hologic Company Profile

        • 14.5.2 Hologic Cancer Biomarkers Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Quest Diagnostics

        • 14.6.1 Quest Diagnostics Company Profile

        • 14.6.2 Quest Diagnostics Cancer Biomarkers Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Agilent Technologies

        • 14.7.1 Agilent Technologies Company Profile

        • 14.7.2 Agilent Technologies Cancer Biomarkers Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Biomérieux SA

        • 14.8.1 Biomérieux SA Company Profile

        • 14.8.2 Biomérieux SA Cancer Biomarkers Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Exact Sciences Corporation

        • 14.9.1 Exact Sciences Corporation Company Profile

        • 14.9.2 Exact Sciences Corporation Cancer Biomarkers Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Sysmex Corporation

        • 14.10.1 Sysmex Corporation Company Profile

        • 14.10.2 Sysmex Corporation Cancer Biomarkers Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Bristol-Myers Squibb Company

        • 14.11.1 Bristol-Myers Squibb Company Company Profile

        • 14.11.2 Bristol-Myers Squibb Company Cancer Biomarkers Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Becton, Dickinson and Company

        • 14.12.1 Becton, Dickinson and Company Company Profile

        • 14.12.2 Becton, Dickinson and Company Cancer Biomarkers Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Roche Diagnostics

        • 14.13.1 Roche Diagnostics Company Profile

        • 14.13.2 Roche Diagnostics Cancer Biomarkers Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Cancer Biomarkers Industry Research Conclusions

    • 15.2 Cancer Biomarkers Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Cancer Biomarkers Industry Market Size (2018-2029)

    • Figure China Cancer Biomarkers Production Volume, Production Value and Growth Rate of Genetic Biomarkers (2018-2029)

    • Figure China Cancer Biomarkers Production Volume, Production Value and Growth Rate of Protein Biomarkers (2018-2029)

    • Figure China Cancer Biomarkers Production Volume, Production Value and Growth Rate of Glyco-biomarkers (2018-2029)

    • Figure China Cancer Biomarkers Sales Volume, Sales Value and Growth Rate of Risk Assessment (2018-2029)

    • Figure China Cancer Biomarkers Sales Volume, Sales Value and Growth Rate of Drug Discovery and Development (2018-2029)

    • Figure China Cancer Biomarkers Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Cancer Biomarkers Sales Volume, Sales Value and Growth Rate of Diagnostics (2018-2029)

    • Figure China Cancer Biomarkers Sales Volume, Sales Value and Growth Rate of Prognostics (2018-2029)

    • Figure North China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure Central China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure South China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure East China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Cancer Biomarkers Market Size and Growth Rate from 2018-2029

    • Figure Cancer Biomarkers Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Cancer Biomarkers Market Share by Type in 2018

    • Figure China Cancer Biomarkers Market Share by Type in 2023

    • Figure China Cancer Biomarkers Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Cancer Biomarkers Production Volume and Growth Rate of Genetic Biomarkers (2018-2023)

    • Figure China Cancer Biomarkers Production Volume and Growth Rate of Protein Biomarkers (2018-2023)

    • Figure China Cancer Biomarkers Production Volume and Growth Rate of Glyco-biomarkers (2018-2023)

    • Figure China Cancer Biomarkers Market Share by Application in 2018

    • Figure China Cancer Biomarkers Market Share by Application in 2023

    • Figure China Cancer Biomarkers Total Market Size and Growth Rate from Consumption End

    • Figure China Cancer Biomarkers Market Size and Growth Rate of Risk Assessment (2018-2023)

    • Figure China Cancer Biomarkers Market Size and Growth Rate of Drug Discovery and Development (2018-2023)

    • Figure China Cancer Biomarkers Market Size and Growth Rate of Others (2018-2023)

    • Figure China Cancer Biomarkers Market Size and Growth Rate of Diagnostics (2018-2023)

    • Figure China Cancer Biomarkers Market Size and Growth Rate of Prognostics (2018-2023)

    • Table China Cancer Biomarkers Production Volume by Region (2018-2023)

    • Table China Cancer Biomarkers Production Volume Share by Region (2018-2023)

    • Figure China Cancer Biomarkers Production Volume Share by Region (2018-2023)

    • Table China Cancer Biomarkers Production Value by Region (2018-2023)

    • Table China Cancer Biomarkers Production Value Share by Region (2018-2023)

    • Figure China Cancer Biomarkers Production Value Share by Region (2018-2023)

    • Table China Cancer Biomarkers Sales Volume by Region (2018-2023)

    • Table China Cancer Biomarkers Sales Volume Share by Region (2018-2023)

    • Figure China Cancer Biomarkers Sales Volume Share by Region (2018-2023)

    • Table China Cancer Biomarkers Sales Value by Region (2018-2023)

    • Table China Cancer Biomarkers Sales Value Share by Region (2018-2023)

    • Figure China Cancer Biomarkers Sales Value Share by Region (2018-2023)

    • Table North China Cancer Biomarkers Production Volume by Type (2018-2023)

    • Table North China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Figure North China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Table North China Cancer Biomarkers Sales Volume by Application (2018-2023)

    • Table North China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure North China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Table Central China Cancer Biomarkers Production Volume by Type (2018-2023)

    • Table Central China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Figure Central China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Table Central China Cancer Biomarkers Sales Volume by Application (2018-2023)

    • Table Central China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure Central China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Table South China Cancer Biomarkers Production Volume by Type (2018-2023)

    • Table South China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Figure South China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Table South China Cancer Biomarkers Sales Volume by Application (2018-2023)

    • Table South China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure South China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Table East China Cancer Biomarkers Production Volume by Type (2018-2023)

    • Table East China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Figure East China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Table East China Cancer Biomarkers Sales Volume by Application (2018-2023)

    • Table East China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure East China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Table Northeast China Cancer Biomarkers Production Volume by Type (2018-2023)

    • Table Northeast China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Figure Northeast China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Table Northeast China Cancer Biomarkers Sales Volume by Application (2018-2023)

    • Table Northeast China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Table Southwest China Cancer Biomarkers Production Volume by Type (2018-2023)

    • Table Southwest China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Figure Southwest China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Table Southwest China Cancer Biomarkers Sales Volume by Application (2018-2023)

    • Table Southwest China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Table Northwest China Cancer Biomarkers Production Volume by Type (2018-2023)

    • Table Northwest China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Figure Northwest China Cancer Biomarkers Production Volume Share by Type (2018-2023)

    • Table Northwest China Cancer Biomarkers Sales Volume by Application (2018-2023)

    • Table Northwest China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Cancer Biomarkers Sales Volume Share by Application (2018-2023)

    • Table FHoffmann-La Roche Ltd Company Profile

    • Table FHoffmann-La Roche Ltd Cancer Biomarkers Revenue, Price and Gross (2018-2023)

    • Table QIAGEN Company Profile

    • Table QIAGEN Cancer Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Cancer Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Bio-Rad Laboratories, Inc Company Profile

    • Table Bio-Rad Laboratories, Inc Cancer Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Hologic Company Profile

    • Table Hologic Cancer Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Quest Diagnostics Company Profile

    • Table Quest Diagnostics Cancer Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Agilent Technologies Company Profile

    • Table Agilent Technologies Cancer Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Biomérieux SA Company Profile

    • Table Biomérieux SA Cancer Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Exact Sciences Corporation Company Profile

    • Table Exact Sciences Corporation Cancer Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Sysmex Corporation Company Profile

    • Table Sysmex Corporation Cancer Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Cancer Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Becton, Dickinson and Company Company Profile

    • Table Becton, Dickinson and Company Cancer Biomarkers Revenue, Price and Gross (2018-2023)

    • Table Roche Diagnostics Company Profile

    • Table Roche Diagnostics Cancer Biomarkers Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.